1. Home
  2. WMK vs AGIO Comparison

WMK vs AGIO Comparison

Compare WMK & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weis Markets Inc.

WMK

Weis Markets Inc.

HOLD

Current Price

$70.68

Market Cap

1.8B

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$28.12

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WMK
AGIO
Founded
1912
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
WMK
AGIO
Price
$70.68
$28.12
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$38.88
AVG Volume (30 Days)
112.3K
1.2M
Earning Date
05-04-2026
04-29-2026
Dividend Yield
1.96%
N/A
EPS Growth
N/A
N/A
EPS
1.13
N/A
Revenue
$4,714,573,000.00
$43,011,000.00
Revenue This Year
N/A
$76.75
Revenue Next Year
N/A
$170.73
P/E Ratio
$62.75
N/A
Revenue Growth
0.01
N/A
52 Week Low
$59.99
$22.24
52 Week High
$79.05
$46.00

Technical Indicators

Market Signals
Indicator
WMK
AGIO
Relative Strength Index (RSI) 52.35 47.19
Support Level $67.90 $26.61
Resistance Level $73.21 $29.39
Average True Range (ATR) 2.04 1.09
MACD -0.00 0.23
Stochastic Oscillator 33.73 76.38

Price Performance

Historical Comparison
WMK
AGIO

About WMK Weis Markets Inc.

Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: